Bergavit
Commercial- Indications
- Cardiovascular health, Metabolic wellness
Company intelligence / Profile preview
NutraGenesis developed and commercialized a portfolio of patented and clinically validated branded nutraceutical ingredients for use in dietary supplements and functional foods. Their products are supported by human clinical trials demonstrating efficacy for various wellness categories including immune support, cardiovascular health, joint function, weight management/metabolic wellness, stress reduction, cognitive function and more. The company was acquired by Innophos Holdings in November 2017 to complement its food/health/nutrition portfolio.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutraGenesis.